GTCR, a leading private equity firm, announced that its portfolio company Resonetics, a pioneer in advanced engineering and manufacturing solutions for the life sciences industry, has acquired Agile MV (“Agile”). Based in Montreal and founded in 2010, Agile is an emerging leader in product development and turnkey device assembly serving the high-growth electrophysiology and interventional cardiology catheter market.
Agile’s expertise in state-of-the-art, minimally invasive and interventional medical devices complements Resonetics’ existing product development capabilities in catheter-based delivery systems and implants. Agile represents the tenth add-on acquisition for Resonetics since GTCR invested in the company in February 2018, and the second since Carlyle’s strategic investment in Resonetics in December 2021. The acquisition furthers the company’s strategy to build a leader in micro-manufacturing for medical devices, targeting fast-growing interventional and minimally invasive applications across the MedTech industry.
Tom Burns, CEO of Resonetics, commented, “Consistent with our initial investment thesis for Resonetics, the acquisition of Agile strategically enhances our capabilities, and further establishes the company’s position as a leading service provider to interventional medical device companies.”
Sean Cunningham, Managing Director and Co-Head of Healthcare at GTCR, added, “We have great respect for what the Agile team has built, and we look forward to our partnership with them. This represents Resonetics’ tenth acquisition since our initial investment, and we expect to continue to aggressively pursue tuck-in acquisitions as well as more transformative opportunities.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Biospace
